Group 1 - The Hang Seng Index rose by 0.42%, gaining 98 points to close at 23,752 points, while the Hang Seng Tech Index increased by 0.92% [1] - Kuaishou-W saw a rise of over 4% due to the launch of its new 2.1 series model, with institutions optimistic about its profitability [1] - Jinli Permanent Magnet surged over 13% as overseas medium and heavy rare earth prices significantly increased, expected to gradually transmit to the domestic market [1] - Hongteng Precision rose over 13% as overseas AI leaders maintain positive capital expenditure plans, benefiting the company's AI business [1] - Xindong Company increased by 6.5% with the launch of the international version of "Yise," and institutions are optimistic about the company's performance growth [1] Group 2 - Weimob Group rose by 4.76% following the upgrade of its Weimob Guide Agent product, positioning the company to benefit from the development of WeChat e-commerce [2] - China National Nuclear Corporation (China Tongfu) increased by over 11% as its fluorine-18 betahistine injection entered Phase III clinical trials [3] - Tianli International Holdings rose nearly 12%, with institutions suggesting that private high school diploma institutions may continue to benefit from a long-term supply-demand gap in the industry [3] - Alibaba Pictures rose by 1%, with institutions optimistic about the sustained box office heat during the summer season, indicating long-term cash flow stability for its To C business [3] - Zhaoke Ophthalmology-B increased by 1.36% after receiving FDA approval for its new drug application for cyclosporine eye gel [3] - Reading Group rose by 5.72% after acquiring a 26.67% stake in Yihua Kaitian, with its IP+AI strategy expected to release more value [3] - Giant Bio fell over 5.63%, having dropped nearly 28% from its previous high, facing ingredient controversies with its skincare brand [3] - Longpan Technology declined over 4% as it plans to issue shares at a nearly 9% discount, raising HKD 117 million [3]